Breaking news

A new line of argument has already come to dominate the public sphere: it’ more The government has gone one step further to detect community spread of the more The government has issued an order to abolish the six allowances, including more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected more SEOUL| South Korea’s unemployment rate was unchanged in April as the more Amid the outbreak of Corona pandemic in the country, Indian government has more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated more Corona infection in the country is taking a macabre form. So far, more than 74 more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh more

Oxford Corona Vaccine Trial Gets Success

Russia Claims Second Corona Vaccine

After lot of rigorous efforts and research, Oxford/AstraZeneca COVID vaccine gets success and as per the information from the sources, the vaccine could be here by October.

As per the information the phase 3 testing of the vaccine has been a great success which was carried out in thousands of humans and is projected to be 80% effective in preventing the severe disease.

As per the information, the university has pledged to produce around two billion doses by the end of this year.

Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodies and “killer T-cells”, a senior source from the trial was quoted by ‘The Daily Telegraph’ as saying.

The discovery is promising because separate studies have suggested that antibodies may fade away within months while T-cells can stay in circulation for years.

Story Page